Scarica l'app Stockscreener
15.45
12.36%
1.70
Dopo l'orario di chiusura:
14.95
-0.50
-3.24%
Precedente Chiudi:
$13.75
Aprire:
$14.04
Volume 24 ore:
189.30K
Relative Volume:
0.34
Capitalizzazione di mercato:
$39.14M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+14.78%
1M Prestazione:
+68.30%
6M Prestazione:
+265.25%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$13.75
$15.46
Intervallo di 1 settimana:
$13.12
$15.65
Portata 52W:
$2.70
$18.00
Quantum Biopharma Ltd Stock (QNTM) Company Profile
Confronta QNTM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
QNTM
Quantum Biopharma Ltd
|
15.45 | 39.14M | 0 | 0 | 0 | 0.00 |
|
ZTS
Zoetis Inc
|
170.16 | 75.08B | 9.29B | 2.52B | 2.28B | 5.57 |
|
HLN
Haleon Plc Adr
|
11.07 | 51.07B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.96 | 46.95B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.77 | 19.24B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
325.82 | 14.38B | 2.99B | 1.21B | 1.13B | 25.06 |
Quantum Biopharma Ltd Borsa (QNTM) Ultime notizie
Quantum Biopharma buys additional $1 million of Bitcoin, other cryptocurrencies - MSN
Quantum BioPharma clarifies misinformation on stock name, RTO rumors By Investing.com - Investing.com South Africa
Quantum BioPharma Ltd. Clarifies Misinformation Regarding Name Change and RTO Rumors - citybuzz -
Quantum BioPharma Clarifies Name Confusion, Refutes RTO Rumors With Unbuzzd Wellness - Nasdaq
Quantum BioPharma Clarifies It Has Not Changed Its Name | QNTM S - GuruFocus
Quantum BioPharma clarifies misinformation on stock name, RTO rumors - Investing.com
Quantum BioPharma clarifies company has not changed its name - TipRanks
Quantum BioPharma (QNTM) Clarifies Company Name and Transaction Rumors | QNTM Stock News - GuruFocus
Quantum BioPharma Addresses Misinformation and Financial Agreements - TipRanks
Quantum BioPharma Addresses Misinformation Regarding Unbuzzd Wellness and Clarifies Stock Trading Platform Errors - Nasdaq
Quantum BioPharma Clarifies It Has Not Changed Its Name - GlobeNewswire
iNGENū CRO Partners with Quantum BioPharma to Launch - GlobeNewswire
Quantum BioPharma settles disputes with former CEO By Investing.com - Investing.com South Africa
Quantum BioPharma Resolves Legal Dispute with Former CEO, Secures $2.35 Million Settlement - citybuzz -
What's Going On With Quantum Biopharma Stock Today? - Benzinga
Quantum BioPharma (QNTM) Settles Disputes with Former CEO | QNTM Stock News - GuruFocus
Quantum BioPharma Settles Legal Dispute with Former CEO, Receives $2.35 Million - TipRanks
Quantum BioPharma settles disputes with former CEO - Investing.com
Quantum Biopharma Brief: Says Received US$2.35 Million From a Mutually-Agreed Global Legal Settlement with Dr. Raza Bokhari - marketscreener.com
Quantum BioPharma Receives $2.35 Million USD from a - GlobeNewswire
Quantum BioPharma Receives $2.35 Million USD from a Mutually-Agreed Global Legal Settlement with Dr. Raza Bokhari - Yahoo Finance
Quantum BioPharma appoints MNP for IPO readiness audits By Investing.com - Investing.com South Africa
Unbuzzd Wellness Prepares for Potential IPO with New Auditor Appointment - citybuzz -
Quantum Biopharma Licensee Celly Nutrition Retains Leading Audit - GuruFocus
Quantum BioPharma (QNTM) Engages New Auditor for Potential IPO | - GuruFocus
Quantum BioPharma (QNTM) Engages New Auditor for Potential IPO | QNTM Stock News - GuruFocus
Quantum BioPharma’s Licensee Unbuzzd Wellness Prepares for IPO with Audit Firm Engagement - TipRanks
Quantum BioPharma announces Unbuzzd Wellness hired audit firm - TipRanks
Quantum BioPharma appoints MNP for IPO readiness audits - Investing.com Australia
Quantum BioPharma Ltd. Announces Unbuzzd Wellness Inc. Hires MNP LLP for PCAOB Audits Ahead of Possible IPO and Company Name Change - Nasdaq
Quantum Biopharma Licensee Celly Nutrition Retains Leading Audit Firm MNP LLP to Advance Capital Raise and Go-Public Readiness and Changes Name To Unbuzzd Wellness Inc. - GlobeNewswire
Quantum BioPharma Receives Ethics Committee Approval for Phase 2 Clinical Trial of FSD202 - marketscreener.com
Quantum Group announces subsidiary received approval by HREC in Australia - TipRanks
Quantum BioPharma (QNTM) Gets Green Light for Australian Clinica - GuruFocus
Quantum BioPharma (QNTM) Gets Green Light for Australian Clinical Trial | QNTM Stock News - GuruFocus
Quantum BioPharma Gains Approval for Phase 2 Trial of FSD202 - TipRanks
Quantum BioPharma Receives Ethics Committee Approval for - GlobeNewswire
Breakthrough MCAS Pain Drug Advances: Quantum BioPharma's FSD202 Cleared for Phase 2 Trial - Stock Titan
Quantum BioPharma selects BitGo to securely store its cryptocurrency assets; - MSN
Quantum BioPharma selects BitGo for crypto custody By Investing.com - Investing.com South Africa
Quantum Biopharma Chooses BitGo to Store Cryptocurrency Holdings - marketscreener.com
Quantum BioPharma (QNTM) Partners with BitGo for Crypto Custody - GuruFocus
Quantum BioPharma Partners with BitGo for Crypto Asset Security - TipRanks
Quantum BioPharma selects BitGo for crypto custody - Investing.com
Quantum BioPharma Ltd. Partners with BitGo Trust for Secure Management of Cryptocurrency Assets - Nasdaq
Quantum BioPharma Partners with BitGo to Securely Store its Crypto Currency Assets - GlobeNewswire
Cannabis Stocks To Follow Today – May 19th - Defense World
Quantum BioPharma advances MS drug towards Phase 2 trial By Investing.com - Investing.com South Africa
Quantum BioPharma advances MS drug towards Phase 2 trial - Investing.com Australia
Quantum Biopharma Announces Signing of an Agreement with a - GlobeNewswire
Endeavour Moves To Adjust Debt, Quantum Boosts Bitcoin Holdings - Finimize
Quantum Biopharma Ltd Azioni (QNTM) Dati Finanziari
Non sono disponibili dati finanziari per Quantum Biopharma Ltd (QNTM). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
3.50%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):